When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sickle Cell Disease - What Is Sickle Cell Disease? - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease

    Sickle cell disease affects more than 100,000 people in the United States and 8 million people worldwide. In the United States, 9 of 10 people who have sickle cell disease are of African ancestry or identify as Black: About 1 in 13 Black babies are born with sickle cell trait, meaning that they inherited a sickle cell gene from one parent.

  3. Sickle Cell Disease - Sickle Cell Trait | NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/sickle-cell-trait

    What is sickle cell trait? Sickle cell trait occurs when a person has one copy of the sickle cell gene passed down from one parent along with a normal hemoglobin gene (hemoglobin A) from the other parent. People who have sickle cell trait are sometimes called carriers . Sickle cell trait is different from sickle cell anemia or sickle cell disease.

  4. Sickle Cell Disease - Causes and Risk Factors - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/causes

    This child has sickle cell trait and is a carrier of the hemoglobin S gene. A 25%, or 1 in 4, chance of inheriting two hemoglobin S genes. This child has sickle cell disease. It is important to keep in mind that each time this couple has a child, the chances of that child having sickle cell disease remain the same.

  5. Questions and answers about sickle cell trait | NHLBI, NIH

    www.nhlbi.nih.gov/news/2010/questions-and-answers-about-sickle-cell-trait

    The National Heart, Lung, and Blood Institute (NHLBI) is currently defining which research questions need to be answered about sickle cell trait. In June 2010, the NHLBI and the Advisory Committee of Blood Safety and Availability in the Office of Public Health and Science, U.S. Department of Health and Human Services, held a two-day scientific ...

  6. Sickle Cell Disease - Treatment | NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/treatment

    View fact sheet. Crizanlizumab-tmca is approved for adults and children ages 16 years and older who have sickle cell disease. The medicine is given through an intravenous (IV) line in the vein once a month. The medicine helps prevent blood cells from sticking to blood vessel walls and blocking blood flow.

  7. Sickle Cell Disease - Diagnosis | NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/diagnosis

    Newborn screening programs also find out whether your baby has sickle cell trait and is a carrier of the hemoglobin S gene. If this is the case, genetic counseling will be offered. Remember that when a child has sickle cell trait or sickle cell disease, their future siblings or your child’s future children may be a carrier of the hemoglobin S ...

  8. Sickle Cell Disease Research - NHLBI, NIH

    www.nhlbi.nih.gov/research/sickle-cell-disease

    Sickle cell trait slightly raised the chance of rhabdomyolysis (muscle damage) with extreme exertion. Studies also suggest that sickle cell trait raises the chance of kidney disease and venous thromboembolism. Detecting early signs of dangerous blood clots: An NHLBI clinical trial is studying blood clotting and markers of inflammation in people ...

  9. Sickle cell disease seems to affect cognitive function in adults

    www.nhlbi.nih.gov/news/2019/sickle-cell-disease-seems-affect-cognitive...

    March 29, 2019. Researchers funded by NHLBI found that adults with sickle cell disease have worse performance in several cognitive tests than their healthy siblings. The disadvantage remained the same even for the patients treated with hydroxyurea. According to the researchers, the study, published in the journal Neuropsychological ...

  10. Cure Sickle Cell Initiative - NHLBI, NIH

    www.nhlbi.nih.gov/science/cure-sickle-cell-initiative

    The Cure Sickle Cell Initiative is an NHLBI-led collaborative research effort that is accelerating the development of gene therapies to cure sickle cell disease. The Initiative identifies and supports promising gene therapies that are currently being tested in multicenter clinical research trials. One of these studies is co-funded by the ...

  11. Enfermedad de Células Falciformes (Sickle cell disease)

    www.nhlbi.nih.gov/es/resources/enfermedad-de-celulas-falciformes-sickle-cell...

    La enfermedad de células falciformes (ECF) es el trastorno sanguíneo hereditario más común en los Estados Unidos. En esta hoja informativa, aprenda sobre las causas, los signos y síntomas, el diagnóstico y el tratamiento de la ECF. (Sickle cell disease (SCD) is the most common inherited blood disorder in the United States.